targeted protein degradation

BMS protein degradation drug research turns to a startup to find molecular glues
MedCity News
Wed, 08/24/22 - 10:14 am
Bristol Myers Squibb
targeted protein degradation
R&D
drug development
A-Alpha Bio
molecular glue
More molecular glue: Plexium pens AbbVie pact months after Amgen deal
Endpoints
Thu, 04/28/22 - 10:59 am
Plexium
molecular glue
AbbVie
targeted protein degradation
neurological disorders
Amgen, Plexium Collaborate To Identify Novel Targeted Protein Degradation Therapies
NASDAQ
Thu, 02/3/22 - 11:34 am
Amgen
Plexium
drug discovery
targeted protein degradation
PAQ Therapeutics scores $30M to unleash “Pac-Man” drugs on neuro disease
MedCity News
Fri, 07/16/21 - 10:36 am
PAQ Therapeutics
funding
neurodegenerative disease
targeted protein degradation
Big Pharma Bets on Body’s Garbage-Disposal System to Beat Cancer
Bloomberg
Thu, 10/10/19 - 07:55 pm
cancer
Arvinas
Kymera
targeted protein degradation
Gilead adds targeted degradation via Nurix deal in quest to strengthen growth areas
BioCentury
Wed, 06/19/19 - 11:15 pm
Gilead Sciences
targeted protein degradation
Bayer inks Arvinas deal to develop protein degraders
Fierce Biotech
Tue, 06/4/19 - 11:56 am
Bayer
Arvinas
targeted protein degradation
AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's
Endpoints
Thu, 11/15/18 - 10:48 am
targeted protein degradation
AbbVie
Mission Therapeutics
Alzheimer's disease
Parkinson's Disease
Pfizer lines up an $830M alliance with Arvinas on protein degradation
Endpoints
Thu, 01/4/18 - 11:23 am
Pfizer
Arvinas
targeted protein degradation
drug development
Genentech inks $650M deal with protein degradation pioneer Arvinas
Endpoints
Wed, 11/15/17 - 11:10 am
Genentech
targeted protein degradation
Arvinas
R&D
Drugging The Undruggable: Kymera's Targeted Protein Degradation
Forbes
Mon, 10/30/17 - 10:01 am
Kymera
targeted protein degradation
drug development